Pfizer reduces ultra-cold requirements for its COVID-19 vaccine
New data submitted to the U.S. Food and Drug Administration from Pfizer claims its mRNA COVID-19 vaccine is stable for longer periods at warmer temperatures than previously thought. The new recommendations suggest the vaccine is stable for two weeks in… Continue reading Pfizer reduces ultra-cold requirements for its COVID-19 vaccine